Forex Trading

Early in November 2020, the drug was denied approval after a marathon seven-hour long virtual meeting with the medical panel disagreeing with the claims. Ten out of 11 members of the federal panel of medical experts voted that it was «not reasonable to consider the research presented as “primary evidence of the effectiveness of Aducanumab …

ICER Updates Report on Aducanumab Pricing, Affirms Agent Is Not Cost-Effective Leer más »

Two-for-one and 3-for-1 stock splits are relatively common, says Holden. While Apple (AAPL) and Tesla (TSLA) have gotten a lot of publicity for their 2020 stock splits, their 5-for-1 or 4-for-1 stock splits were uncommon choices. The process of a stock split is expensive, requires legal oversight, and must be performed in accordance with regulatory …

Stock Splits: What They Are, How They Affect Your Portfolio Leer más »

While Aducanumab has been approved by FDA, there has been a major controversy over the clinical trials conducted to test the drug. While the first showed some improvement in patients, the second failed to show any benefit. In the base case, aducanumab’s value-based price was $2000/y from a health care sector perspective and $3000/y from …

Aducanumab Wikipedia Leer más »

Early in November 2020, the drug was denied approval after a marathon seven-hour long virtual meeting with the medical panel disagreeing with the claims. Ten out of 11 members of the federal panel of medical experts voted that it was «not reasonable to consider the research presented as “primary evidence of the effectiveness of Aducanumab …

ICER Updates Report on Aducanumab Pricing, Affirms Agent Is Not Cost-Effective Leer más »